HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

József Tóvári Selected Research

Erythropoietin Receptors (Erythropoietin Receptor)

12/2015[Excerpts from the collaborative lung cancer research program of Semmelweis University, the National Institute of Oncology and Korányi Institute of TB and Pulmonology (2010-2015)].
1/2013Erythropoietin receptor expression is a potential prognostic factor in human lung adenocarcinoma.
1/2008Recombinant human erythropoietin alpha improves the efficacy of radiotherapy of a human tumor xenograft, affecting tumor cells and microvessels.
1/2007[Human recombinant erythropoietin-alpha increases the efficacy of irradiation in preclinical model].
8/2005Recombinant human erythropoietin alpha targets intratumoral blood vessels, improving chemotherapy in human xenograft models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


József Tóvári Research Topics

Disease

47Neoplasms (Cancer)
01/2022 - 01/2005
15Melanoma (Melanoma, Malignant)
11/2021 - 01/2005
10Neoplasm Metastasis (Metastasis)
11/2021 - 01/2005
5Squamous Cell Carcinoma of Head and Neck
05/2022 - 06/2011
3Hypoxia (Hypoxemia)
11/2021 - 01/2008
3Breast Neoplasms (Breast Cancer)
11/2021 - 10/2017
3Colorectal Neoplasms (Colorectal Cancer)
07/2020 - 01/2016
3Carcinoma (Carcinomatosis)
01/2020 - 01/2012
3Colonic Neoplasms (Colon Cancer)
09/2019 - 12/2015
2Pancreatic Neoplasms (Pancreatic Cancer)
06/2020 - 12/2019
2Leukemia
10/2018 - 12/2015
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2015 - 01/2013
2Prostatic Neoplasms (Prostate Cancer)
09/2014 - 07/2011
1Head and Neck Neoplasms (Head and Neck Cancer)
05/2022
1Inflammation (Inflammations)
01/2022
1Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
01/2022
1Cardiomyopathies (Cardiomyopathy)
01/2022
1Kaposi Sarcoma (Kaposi's Sarcoma)
01/2021
1Lung Neoplasms (Lung Cancer)
07/2020
1Osteoporosis
07/2020
1Genomic Instability
02/2020
1Triple Negative Breast Neoplasms
02/2020
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2019
1Tics (Tic)
09/2019
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
08/2019

Drug/Important Bio-Agent (IBA)

13Pharmaceutical PreparationsIBA
07/2020 - 08/2005
7Peptides (Polypeptides)IBA
01/2021 - 01/2016
7Proteins (Proteins, Gene)FDA Link
01/2020 - 07/2007
6Daunorubicin (Cerubidine)FDA LinkGeneric
01/2021 - 01/2012
5Erythropoietin Receptors (Erythropoietin Receptor)IBA
12/2015 - 08/2005
4Zoledronic Acid (Zometa)FDA Link
07/2020 - 01/2015
4gonadotropin-releasing hormone-IIIIBA
09/2019 - 01/2012
4Heparin (Liquaemin)FDA LinkGeneric
12/2015 - 01/2004
4ErythropoietinFDA Link
09/2008 - 08/2005
3Cetuximab (Erbitux)FDA Link
05/2022 - 01/2021
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2021 - 08/2005
3LigandsIBA
11/2021 - 01/2005
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
02/2021 - 05/2018
3Diphosphonates (Bisphosphonates)IBA
07/2020 - 12/2015
3Biological ProductsIBA
09/2019 - 01/2005
3Doxorubicin (Adriamycin)FDA LinkGeneric
10/2017 - 08/2005
3Hemoglobins (Hemoglobin)IBA
01/2008 - 08/2005
2ApelinIBA
11/2021 - 12/2015
2Adenosine Triphosphate (ATP)IBA
02/2021 - 07/2007
2IntegrinsIBA
01/2021 - 07/2020
2NGR peptideIBA
01/2021 - 07/2020
2AZD 6244IBA
10/2020 - 05/2018
2Protein Isoforms (Isoforms)IBA
07/2020 - 01/2020
2hydroxide ionIBA
07/2020 - 06/2020
2BPH1222IBA
07/2020 - 10/2019
2AntigensIBA
01/2020 - 12/2019
2Monomeric GTP-Binding ProteinsIBA
10/2019 - 07/2017
2LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
09/2019 - 01/2016
2ErbB Receptors (EGF Receptor)IBA
12/2018 - 06/2011
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
10/2017 - 01/2017
2OximesIBA
01/2016 - 01/2012
2Cytostatic AgentsIBA
12/2015 - 07/2011
2CalciumIBA
11/2015 - 08/2015
2DNA (Deoxyribonucleic Acid)IBA
07/2007 - 08/2005
1epidermal growth factor receptor VIIIIBA
05/2022
1LipopolysaccharidesIBA
01/2022
1Green Fluorescent ProteinsIBA
01/2022
1Troponin IIBA
01/2022
1Growth Differentiation Factor 15IBA
01/2022
1DiarylheptanoidsIBA
01/2022
1Dosage Forms (Dosage Form)IBA
01/2022
1SulfurIBA
11/2021
1LyasesIBA
11/2021
1Sulfides (Thioethers)IBA
11/2021
1Ligases (Synthetase)IBA
11/2021
1EnzymesIBA
11/2021
1Cystine (L-Cystine)IBA
11/2021
1Cysteine (L-Cysteine)FDA Link
11/2021
1trametinibIBA
02/2021
1Tyrosine Kinase InhibitorsIBA
01/2021
1Cyclic PeptidesIBA
01/2021
1((3Z)- N- (3- chlorophenyl)- 3- ((3,5- dimethyl- 4- ((4- methylpiperazin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- N- methyl- 2- oxo- 2,3- dihydro- 1H- indole- 5- sulfonamide)IBA
01/2021
1dactolisibIBA
10/2020
1CopperIBA
05/2020
1neocuproineIBA
05/2020
1Liposomes (Liposome)IBA
05/2020
1Cisplatin (Platino)FDA LinkGeneric
02/2020
1talazoparibIBA
02/2020
1Poly(ADP-ribose) Polymerase InhibitorsIBA
02/2020
1veliparibIBA
02/2020
1olaparibIBA
02/2020
1rucaparibIBA
02/2020
1PlatinumIBA
02/2020
1p38 Mitogen-Activated Protein KinasesIBA
01/2020
1Phosphotransferases (Kinase)IBA
12/2019
1tyrosine receptor (receptor, tyrosine)IBA
12/2019
1Antineoplastic Agents (Antineoplastics)IBA
12/2019
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
09/2019
1Biomarkers (Surrogate Marker)IBA
08/2019
1Galactosylceramides (Galactocerebrosides)IBA
08/2019
1Pentoxifylline (Trental)FDA LinkGeneric
08/2019

Therapy/Procedure

27Therapeutics
05/2022 - 01/2005
6Drug Therapy (Chemotherapy)
02/2020 - 08/2005
4Radiotherapy
08/2019 - 01/2008
2Molecular Targeted Therapy
11/2021 - 08/2019